Wakefield Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Wakefield Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,280	Closed	-$494K	–	199
2019 Q3	$494K	Buy	7,280 +150	+2%	+$10.3K	0.22%	123
2019 Q2	$415K	Sell	7,130 -579	-8%	-$34.3K	0.16%	131
2019 Q1	$540K	Buy	7,709 +2,074	+37%	+$154K	0.2%	122
2018 Q4	$363K	Buy	+5,635	New	+$395K	0.16%	118

Wakefield Asset Management's GHDX Position: Q4 2019 in Review

Wakefield Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 7,280 shares — an estimated $494K sold.

Wakefield Asset Management first reported a position in GHDX in Q4 2018 and held it in 4 quarters. The position peaked at $540K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Wakefield Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Wakefield Asset Management sold 7,280 Genomic Health, Inc. shares in Q4 2019, an estimated $494K.
Wakefield Asset Management first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 4 quarters.
Wakefield Asset Management's Genomic Health, Inc. position peaked at $540K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Wakefield Asset Management's 13F filing for Q4 2019, filed 27 Jan 2020.